Global Autoinjectors Market 2023-2027

Description

List of Tables

Technavio has been monitoring the autoinjectors market and is forecast to grow by $134014.58 mn during 2022-2027, accelerating at a CAGR of 25.14% during the forecast period. Our report on the autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies and the need for immediate care, the growing popularity of injectable therapies, and the rise in commercial approvals of new products.

Technavio's autoinjectors market is segmented as below:

By Application

Anaphylaxis
Multiple sclerosis
Rheumatoid arthritis
Diabetes

By End-user

Hospitals and clinics
Self-administration

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strategic alliances between companies as one of the prime reasons driving the autoinjectors market growth during the next few years. Also, increase in new product launches and rise in awareness of innovative anaphylaxis autoinjectors will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the autoinjectors market covers the following areas:

Autoinjectors market sizing
Autoinjectors market forecast
Autoinjectors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoinjectors market vendors that include AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Halozyme Therapeutics Inc., Johnson and Johnson Services Inc., Johnson Medtech LLC, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., RAVIMED Sp. zoo, Recipharm AB, SHL Medical AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed AG. Also, the autoinjectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR70391

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global autoinjectors market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global autoinjectors market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Anaphylaxis - Market size and forecast 2022-2027
Exhibit 34: Chart on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Anaphylaxis - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Anaphylaxis - Year-over-year growth 2022-2027 (%)
6.4 Multiple sclerosis - Market size and forecast 2022-2027
Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
6.5 Rheumatoid arthritis - Market size and forecast 2022-2027
Exhibit 42: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
6.6 Diabetes - Market size and forecast 2022-2027
Exhibit 46: Chart on Diabetes - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Diabetes - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Diabetes - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Diabetes - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ million)
Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 56: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
7.4 Self-administration - Market size and forecast 2022-2027
Exhibit 60: Chart on Self-administration - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Self-administration - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Self-administration - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Self-administration - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 119: Amgen Inc. - Overview
Exhibit 120: Amgen Inc. - Product / Service
Exhibit 121: Amgen Inc. - Key offerings
12.5 Bayer AG
Exhibit 122: Bayer AG - Overview
Exhibit 123: Bayer AG - Business segments
Exhibit 124: Bayer AG - Key news
Exhibit 125: Bayer AG - Key offerings
Exhibit 126: Bayer AG - Segment focus
12.6 Becton Dickinson and Co.
Exhibit 127: Becton Dickinson and Co. - Overview
Exhibit 128: Becton Dickinson and Co. - Business segments
Exhibit 129: Becton Dickinson and Co. - Key news
Exhibit 130: Becton Dickinson and Co. - Key offerings
Exhibit 131: Becton Dickinson and Co. - Segment focus
12.7 Eli Lilly and Co.
Exhibit 132: Eli Lilly and Co. - Overview
Exhibit 133: Eli Lilly and Co. - Product / Service
Exhibit 134: Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 140: GlaxoSmithKline Plc - Overview
Exhibit 141: GlaxoSmithKline Plc - Business segments
Exhibit 142: GlaxoSmithKline Plc - Key news
Exhibit 143: GlaxoSmithKline Plc - Key offerings
Exhibit 144: GlaxoSmithKline Plc - Segment focus
12.10 Halozyme Therapeutics Inc.
Exhibit 145: Halozyme Therapeutics Inc. - Overview
Exhibit 146: Halozyme Therapeutics Inc. - Product / Service
Exhibit 147: Halozyme Therapeutics Inc. - Key offerings
12.11 Merck KGaA
Exhibit 148: Merck KGaA - Overview
Exhibit 149: Merck KGaA - Business segments
Exhibit 150: Merck KGaA - Key news
Exhibit 151: Merck KGaA - Key offerings
Exhibit 152: Merck KGaA - Segment focus
12.12 Owen Mumford Ltd.
Exhibit 153: Owen Mumford Ltd. - Overview
Exhibit 154: Owen Mumford Ltd. - Product / Service
Exhibit 155: Owen Mumford Ltd. - Key offerings
12.13 Pfizer Inc.
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product / Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
12.14 Recipharm AB
Exhibit 160: Recipharm AB - Overview
Exhibit 161: Recipharm AB - Business segments
Exhibit 162: Recipharm AB - Key offerings
Exhibit 163: Recipharm AB - Segment focus
12.15 Teva Pharmaceutical Industries Ltd.
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 Viatris Inc.
Exhibit 169: Viatris Inc. - Overview
Exhibit 170: Viatris Inc. - Business segments
Exhibit 171: Viatris Inc. - Key offerings
Exhibit 172: Viatris Inc. - Segment focus
12.17 Ypsomed AG
Exhibit 173: Ypsomed AG - Overview
Exhibit 174: Ypsomed AG - Business segments
Exhibit 175: Ypsomed AG - Key offerings
Exhibit 176: Ypsomed AG - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations